With no change in the Part D DIR process in the recently adopted HHS Part D rule, pharmacy is shifting all its focus to Congress for a fix to DIR fees that have increased over 45,000 percent since 2010.

With no change in the Part D DIR process in the recently adopted HHS Part D rule, pharmacy is shifting all its focus to Congress for a fix to DIR fees that have increased over 45,000 percent since 2010.

Since recent Pennsylvania State Auditor General highly critical reports of Pennsylvania's Medicaid Managed care PBM run prescription program, IPC is now working with the Pennsylvania Pharmacists Association and other Pennsylvania pharmacy groups to push the following state 5 bill legislative package to reform the PA MCO prescription drug program.

Illinois House Majority Leader Greg Harris is pushing hard for the “Prescription Drug Affordability & Accessibility Act HB 465

As outlined in California's State Plan Amendment 17-002, DHCS is implementing a new FFS reimbursement methodology for covered outpatient drugs. Barring unforeseen delay, DHCS anticipates FFS pharmacy providers will see the new reimbursement methodology reflected in their claims with dates of service starting February 23, 2019. Because the policy effective date mandated by CMS is April 1, 2017, DHCS intends to make retroactive adjustments for all claims with dates of service between April 1, 2017, and the implementation date.

IPC’s Government Relations team encourages members in the Texas area to attend the Texas Pharmacy Day at the Capital. The event will take place Tuesday, February 26th at First United Methodist Church in Austin, Texas. Presented by the Alliance of Independent Pharmacists of Texas, the goal is to unite multiple independent pharmacy interests on legislative and regulatory issues, while promoting the profession. Register online at www.aiptexas.org today!